Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-11-28T13:55:04.108Z Has data issue: false hasContentIssue false

L'ocytocine dans le traitement du trouble obsessionnel: un rapport négatif à propos de deux cas

Published online by Cambridge University Press:  28 April 2020

G. Charles
Affiliation:
Hôpital Vincent Van Gogh, rue de l'hôpital, 55, B-6030 Marchienne-au-Pont, Belgique
R. Guillaume
Affiliation:
Hôpital Vincent Van Gogh, rue de l'hôpital, 55, B-6030 Marchienne-au-Pont, Belgique
M. Schittecatte
Affiliation:
Hôpital Vincent Van Gogh, rue de l'hôpital, 55, B-6030 Marchienne-au-Pont, Belgique
P. Pholien
Affiliation:
Hôpital Vincent Van Gogh, rue de l'hôpital, 55, B-6030 Marchienne-au-Pont, Belgique
J.P. Van Wettere
Affiliation:
Hôpital Vincent Van Gogh, rue de l'hôpital, 55, B-6030 Marchienne-au-Pont, Belgique
J. Wilmotte
Affiliation:
Hôpital Vincent Van Gogh, rue de l'hôpital, 55, B-6030 Marchienne-au-Pont, Belgique
Get access

Résumé

Deux patients, un homme de 43 ans et une femme de 24 ans, répondant aux critères diagnostiques du trouble obsessionnel compulsif ont été traités par ocytocine à 10 UI/jour, en intramusculaire. L'ocytocine est un nona-peptide hypophysaire dont la propriété d'altérer la mémoire est connue chez l'animal et chez l'homme. Une rémission relative du trouble obsessionnel compulsif a récemment été signalée lors d'un traitement prolongé par ocytocine intranasale. Nous n'avons, quant à nous, observé aucune amélioration des symptômes obsessionnels compulsifs (évalués selon la liste du Maudsley Hospital) durant les 15 à 20 jours de traitement. Les implications liées au mode d'administration sont discutées, de même que le rôle joué par d'éventuelles manifestations psychopathologiques survenant en cours de traitement.

Summary

Summary

Oxytocin is known to alter memory functions in both man and animal recently, clinical improvement of an obsessive-compulsive patient under ocytocine has been reported. Two inpatients, a 24-year-old female and a 43-year-old male suffering from obsessive-compulsive disorder, were treated with oxytocin IM (10 UI/day) during 2 years and 3 weeks, respectively. We did not observe any symptomatic improvement. Symptoms were assessed according to the Maudsley Inventory. Influences of pharmacokinetic parameters of the peptide and of preexistant psychopathology are discussed.

Type
Fait clinique
Copyright
Copyright © European Psychiatric Association 1989

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Références

Ang, V.T.Y. & Jenkins, J.S. (1982) Blood-cerebrospinal fluid barrier to arginine-vasopressin, desmopressin desglycinamide arginine-vasopressin in the dog. J. Endocrinol. 93, 319325CrossRefGoogle ScholarPubMed
Ansseau, M.Legros, J.J.Mormont, GCerfontaine, J.L.Papart, P.Geenen, V.Adam, F. & Franck, G. (1987) Intranasal oxytocin in obsessive-compulsive disorder. Psychoneuroendocrinology 12, 231236CrossRefGoogle ScholarPubMed
Chapman, L.J. (1979) Recent advances in the study of schizophrenic cognition. Schizophr. Bull. V, 4, 568580CrossRefGoogle Scholar
Charles, G. & Ansseau, M. (1987) Guide pour le diagnostic des troubles affectifs et de la schizophrénie. Acta Psychiatr. Belg. 87, 361516Google Scholar
Fehm-Wolfsdorf, G.Bachholz, G.Born, J.Voigt, K. & Fehm, H.L. (1988) Vasopressin but not oxytocin enhances cortical arousal : an integrative hypothesis on behavioral effects of neurohypophyseal hormones. Psychopharmacology 94, 496500CrossRefGoogle Scholar
Fehm-Wolfsdorf, G.Voigt, K.H. & Fehm, H.L. (1984) Human memory and neurohypophyseal hormones: opposite effects of vasopressin and oxytocin. Psychoneuroendocrinology 9, 285292CrossRefGoogle ScholarPubMed
Ferrier, B.M.Kennett, D.J. & Devlin, M.C. (1980) Influence of oxytocin on human memory processes. Life Sci. 27, 23112317CrossRefGoogle ScholarPubMed
Fink, M. (1979) Convulsive Therapy: Theory and Practice. Raven Press, New YorkGoogle Scholar
Hamilton, M. (I960) A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23, 5662CrossRefGoogle Scholar
Insel, T.R. (1984) New Findings in Obsessive-Compulsive Disorder. American Psychiatric Press, WashingtonGoogle Scholar
Kovacs, O.L. & Telegdy, I. (1982) Role of oxytocin in memory and amnesia. Pharmacol. Ther. 18, 375395CrossRefGoogle ScholarPubMed
Landgraf, R. (1985) Plasma oxytocin concentrations in man after different routes of administration of synthetic oxytocin. Exp. Clin. Endocrinol. 85, 245248CrossRefGoogle ScholarPubMed
Marks, I.M.Hallam, R.S. & Phellepot, R. (1987) Nursing in Behavioral Psychotherapy: Research Series of the Royal College of Nursing, Royal College of Nursing, LondonGoogle Scholar
Mellman, L.A. & Gorman, J.M. (1984) Successful treatment of obsessive compulsive disorder with ECT. Am. J. Psychiatry 141, 596597Google ScholarPubMed
Norman, A.W. & Litwack, G. (1987) Hormones. Academic Press, OrlandoGoogle ScholarPubMed
Salzman, L. & Thaler, F.M. (1981) Obsessive-compulsive disorders: a review. Am. J. Psychiatry 138, 286296Google ScholarPubMed
Schultz, H.Kovacs, G.L. & Telegdy, G. (1976) The effect of vasopressin and oxytocin on avoidance behavior in rats. In: Cellular and Molecular Bases of Neuroenocrine process, (Endoczy, E., ed) Akademiai Kiado, Budapest, p. 555564Google Scholar
Taylor, J.L. & Tinklenberg, J.R. (1987) Cognitive impairment and benzodiazepines. In: Psychopharmacology (Meltzer, H.Y., ed.) Raven Press, New York, p. 1449Google Scholar
Zohar, J. & Insel, T.R. (1987) Drug treatment of obsessive-compulsive disorder: J. Affective Dis. 13, 193202CrossRefGoogle Scholar
Submit a response

Comments

No Comments have been published for this article.